Section 2 mCRPC Progression
For CME-certification information and other resources, visit www.IMERonline.com/CRPCvide...
Medical oncologists, urologists, radiation oncologists, and other healthcare professionals involved in the treatment of patients with castration-resistant prostate cancer (CRPC). There are no prerequisites.
The goal for this activity is to provide clinicians with the latest emerging evidence in CRPC that can be applied in clinical practice to improve disease management and ultimately patient outcomes.
This video on-demand series will bring together a panel of expert thought leaders to discuss the optimal management and emerging agents across the CRPC treatment continuum. Topics will include identification and initial treatment of CRPC, metastatic CRPC progression, future novel treatment for patients with CRPC, and expert perspectives on a case study example to decipher optimal treatment of CRPC.